On Our Radar GGII, ENTB, VYGO, and GSRE
GGII has released some impressive news recently and it looks like this company is coming “back to life” in a big way. We continue to hold the substantial position we purchased and wait for what we believe is the imminent break of a dime and run higher.
ENTB has been a beauty. Although not one of the highest percentage gainers we’ve ever called, ENTB daily shows strength and could very well become one of the highest percentage gainers we’ve called! Since our first alert given at $1.10 the stock is up about 100% but we think there’s more in store for this gem that specializes in medical treatments using adult stem cells.
VYGO what can we say? The OTC Times has been assured by large investors in VYGO that they believe this will become an amazing play. If recent news is an indicator we tend to agree. This one will likely “go” when we’re least expecting it, in the meantime we continue to hold our position and even add more.
GSRE remains at the top of our list of sub-penny picks. Watch this one close we think there’s a move in store when the company begins releasing news again.








